Centre of Excellence for Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

*

Key objectives:

  • Defining the best practices for the conduct of RDCTs.

  • Identifying technologies and other operational innovative approaches for RDCTs and selecting the appropriate technology package to be used for the pan-EU pilot.

  • Designing and running a pan-EU pilot, comparing the scientific and operational quality of the RDCT with traditional trial approaches and evaluating the feasibility of the RDCT.

  • Identifying, mapping and analysing the relevant ethical, quality, regulatory, legal and organisational barriers and enablers of RDCTs.

  • Consulting with stakeholders and promoting the outcomes from the Trials@Home consortium through targeted communication, dissemination and training activities.

  • Providing recommendations with supporting tools for implementing RDCTs in Europe and contributing to the update of ICH guidelines on RDCTs.

More
*

About us

*

About RDCT’s

*

About the ESP & PEP

News & publications

*

UMCU is looking for a PhD to join their team for the Trials@Home project

15 July, Utrecht

We offer a PhD position in which you will explore patient preferences and other aspects of Remote Decentralised Clinical Trials. We are looking for an inquisitive, driven researcher, interested to work in an international multi-stakeholder consortium.

Apply here

Trials@Home celebrated its annual meeting’s extra spring edition – Public Report

23 June – Virtual

After nearly 2 years of intense work and study in the field of decentralised clinical trials, more than 120 Trials@Home colleagues met up in a virtual semi-annual meeting in April 2021 to reflect on all the progress made in the project until now. The meeting was held over two days and included work packages updates and a series of scientific sessions to stimulate the debate and discuss the future of clinical trials. “While we have a lot to celebrate, we certainly have a lot to accomplish over the next year so let’s keep up the good momentum and, the good engagement”. These words by Kimberly Hawkins, overall industry project lead and WP1 co-leader from Sanofi, served as the starting signal of the event.

Read the full report

COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union

First published: 05 March 2021

Authors: Amos Jochanan de Jong, Yared Santa‐Ana‐Tellez, Ghislaine José Madeleine Wilhelmien van Thiel, Mira Gerta Petra Zuidgeest, Satu Johanna Siiskonen, Dinesh Mistry, Anthonius de Boer, Helga Gardarsdottir. On behalf of the Trials@Home Consortium

Follow us on Twitter
Sign up for our Newsletter